MX2009010207A - Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c. - Google Patents
Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c.Info
- Publication number
- MX2009010207A MX2009010207A MX2009010207A MX2009010207A MX2009010207A MX 2009010207 A MX2009010207 A MX 2009010207A MX 2009010207 A MX2009010207 A MX 2009010207A MX 2009010207 A MX2009010207 A MX 2009010207A MX 2009010207 A MX2009010207 A MX 2009010207A
- Authority
- MX
- Mexico
- Prior art keywords
- hcv
- hydrazido
- protease
- peptides
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención describe compuestos novedosos, que tienen actividad inhibidora de proteasa de HCV así como métodos para preparar dichos compuestos; en otra modalidad, la invención describe composiciones farmacéuticas que comprenden los compuestos así como métodos para usarlos para tratar trastornos asociados con la proteasa de HCV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91973207P | 2007-03-23 | 2007-03-23 | |
PCT/US2008/003654 WO2008118332A2 (en) | 2007-03-23 | 2008-03-20 | Hydrazido-peptides as inhibitors of hcv ns3-protease |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009010207A true MX2009010207A (es) | 2009-10-19 |
Family
ID=39789182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009010207A MX2009010207A (es) | 2007-03-23 | 2008-03-20 | Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20100104534A1 (es) |
EP (1) | EP2139911A2 (es) |
JP (1) | JP2010522174A (es) |
CN (1) | CN101679483A (es) |
CA (1) | CA2681598A1 (es) |
MX (1) | MX2009010207A (es) |
WO (1) | WO2008118332A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2678577A1 (en) | 2007-02-26 | 2008-09-04 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
JP5451611B2 (ja) | 2007-07-26 | 2014-03-26 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター |
AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
WO2009075835A1 (en) | 2007-12-11 | 2009-06-18 | Vitae Pharmaceutical, Inc | CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
TW200934490A (en) | 2008-01-07 | 2009-08-16 | Vitae Pharmaceuticals Inc | Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1 |
EP2252601B1 (en) | 2008-01-24 | 2012-12-19 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
JP5734666B2 (ja) | 2008-02-11 | 2015-06-17 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤 |
JP5730021B2 (ja) | 2008-02-15 | 2015-06-03 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤としてのシクロアルキルラクタム誘導体 |
CA2723034A1 (en) | 2008-05-01 | 2009-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
WO2009134392A1 (en) | 2008-05-01 | 2009-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
BRPI0911764A2 (pt) | 2008-05-01 | 2015-10-06 | Boehringer Ingelheim Int | inibidores cíclicos de 11beta-hidroxiesteroide desigrogenase 1 |
JP5451752B2 (ja) | 2008-05-01 | 2014-03-26 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター |
CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
PE20110566A1 (es) | 2008-07-25 | 2011-09-02 | Boehringer Ingelheim Int | Inhibidores ciclicos de 11beta-hidroxiesteroide deshidrogenasa 1 |
CA2744946A1 (en) | 2009-02-04 | 2010-08-12 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
US8680093B2 (en) | 2009-04-30 | 2014-03-25 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
EP2440537A1 (en) | 2009-06-11 | 2012-04-18 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
US8883778B2 (en) | 2009-07-01 | 2014-11-11 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
EP2516434B1 (en) | 2009-12-23 | 2015-05-27 | Takeda Pharmaceutical Company Limited | Fused heteroaromatic pyrrolidinones as syk inhibitors |
EP2582698B1 (en) | 2010-06-16 | 2016-09-14 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
EP2585444B1 (en) | 2010-06-25 | 2014-10-22 | Boehringer Ingelheim International GmbH | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
CN103179960A (zh) | 2010-11-02 | 2013-06-26 | 贝林格尔.英格海姆国际有限公司 | 治疗代谢疾病的药物组合 |
US9056873B2 (en) | 2011-06-22 | 2015-06-16 | Takeda Pharmaceutical Company Limited | Substituted 6-aza-isoindolin-1-one derivatives |
WO2022020711A1 (en) * | 2020-07-24 | 2022-01-27 | The Texas A&M University System | Sars-cov-2 main protease inhibitors |
CN114989045B (zh) * | 2022-06-14 | 2023-09-08 | 斯坦德药典标准物质研发(湖北)有限公司 | 合成奈玛特韦的中间体及其制法以及合成奈玛特韦的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0100100A3 (en) * | 1997-08-11 | 2001-12-28 | Boehringer Ingelheim Ca Ltd | Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use |
US6624290B2 (en) * | 2000-02-08 | 2003-09-23 | Schering Corporation | Azapeptides useful in the treatment of Hepatitis C |
EP1713822B1 (en) * | 2004-01-30 | 2010-03-17 | Medivir AB | Hcv ns-3 serine protease inhibitors |
US7173057B2 (en) * | 2004-02-27 | 2007-02-06 | Schering Corporation | Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus |
CN101068828A (zh) * | 2004-08-27 | 2007-11-07 | 先灵公司 | 用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的酰基磺酰胺化合物 |
-
2008
- 2008-03-20 EP EP08742156A patent/EP2139911A2/en not_active Ceased
- 2008-03-20 WO PCT/US2008/003654 patent/WO2008118332A2/en active Application Filing
- 2008-03-20 JP JP2009554572A patent/JP2010522174A/ja not_active Withdrawn
- 2008-03-20 US US12/532,223 patent/US20100104534A1/en not_active Abandoned
- 2008-03-20 CN CN200880016894A patent/CN101679483A/zh active Pending
- 2008-03-20 MX MX2009010207A patent/MX2009010207A/es not_active Application Discontinuation
- 2008-03-20 CA CA002681598A patent/CA2681598A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008118332A3 (en) | 2009-02-19 |
WO2008118332A2 (en) | 2008-10-02 |
JP2010522174A (ja) | 2010-07-01 |
CN101679483A (zh) | 2010-03-24 |
CA2681598A1 (en) | 2008-10-02 |
EP2139911A2 (en) | 2010-01-06 |
US20100104534A1 (en) | 2010-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009010207A (es) | Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c. | |
AU2018236800B2 (en) | DNA-PK inhibitors | |
MX2009011064A (es) | Compuestos de azufre como inhibidores de la serina proteasa ns3 del virus de la hepatitis c. | |
MX2009010205A (es) | Inhibidores de cetoamida p1-no epimerizables de proteasa ns3 de virus de hepatitis c. | |
TW200938526A (en) | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease | |
TW200602037A (en) | Novel compounds as inhibitors of hepatitis C virus NS3 serine protease | |
TWI265927B (en) | Novel compounds as NS3-serine protease inhibitors of hepatitis C virus | |
TN2014000016A1 (en) | 4 - piperidinyl compounds for use as tankyrase inhibitors | |
WO2010083207A3 (en) | Protein kinase c inhibitors and uses thereof | |
MX2010004704A (es) | Inhibidores macrociclicos de la ns3 serina proteasa del virus de la hepatitis c. | |
TN2013000348A1 (en) | Compounds and compositions as trk inhibitors | |
MY148253A (en) | Azaadamantane derivatives and methods of use | |
MX2009008253A (es) | Derivados de 2-aminopiridina utiles como inhibidores de cinasa. | |
MX2009007944A (es) | Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium. | |
WO2012135113A3 (en) | Cyclopropylamines as lsd1 inhibitors | |
WO2013163190A8 (en) | Dna-pk inhibitors | |
WO2005087725A3 (en) | Novel compounds as inhibitors of hepatitis c virus ns3 serine protease | |
TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
MX2009009491A (es) | Compuestos y composiciones como moduladores de la actividad del gpr119. | |
WO2010151799A3 (en) | Compounds for modulating rna binding proteins and uses therefor | |
WO2010151797A3 (en) | Compounds for modulating rna binding proteins and uses therefor | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
WO2010021717A3 (en) | Hcv protease inhibitors | |
MX2011014019A (es) | Derivados de diazahomoadamantano y sus metodos de uso. | |
MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FA | Abandonment or withdrawal |